Phase 1/2 Clinical Trial of Interferon α2b and Weekly Liposome-encapsulated All-trans Retinoic Acid in Patients With Advanced Renal Cell Carcinoma-Reference-Cited by-同舟云学术

Phase 1/2 Clinical Trial of Interferon α2b and Weekly Liposome-encapsulated All-trans Retinoic Acid in Patients With Advanced Renal Cell Carcinoma

Published:2007-09 Issue:6 Volume:30 Page:655-662
ISSN:1524-9557
Container-title:Journal of Immunotherapy
language:en
Short-container-title:

Author:

Boorjian Stephen A.,Milowsky Matthew I.,Kaplan Jodi,Albert Martin,Cobham Marta Vallee,Coll Deirdre M.,Mongan Nigel P.,Shelton Gary,Petrylak Daniel,Gudas Lorraine J.,Nanus David M.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cancer Research,Pharmacology,Immunology,Immunology and Allergy

Reference43 articles.

1. Cancer statistics, 2004;Jemal;CA Cancer J Clin,2004

2. Interferon in metastatic renal cell carcinoma;Fossa;Semin Oncol,2000

3. Interleukin-2 in the treatment of renal cancer;Margolin;Semin Oncol,2000

4. Renal cell carcinoma: current status and future directions;Martel;Crit Rev Oncol Hematol,2003

5. Randomized study of high-dose and low-dose interleukin-2 in patients with metastatic renal cancer;Yang;J Clin Oncol,2003

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Promising future: a review of clinical applications of biopolymers in renal cell carcinoma;Journal of Cancer Metastasis and Treatment;2024-04-18

2. A systematic review of nanocarriers for treatment of urologic cancers;Urologic Oncology: Seminars and Original Investigations;2023-12

3. Vitamin A and retinoid signaling in the kidneys;Pharmacology & Therapeutics;2023-08

4. Direct and indirect effects of IFN-α2b in malignancy treatment: not only an archer but also an arrow;Biomarker Research;2022-09-14

5. Synthetic Retinoids Beyond Cancer Therapy;Annual Review of Pharmacology and Toxicology;2022-01-06